NM_000233.4:c.430G>A

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 3P and 13B. PM5PP2BP4_StrongBP6BS1BS2

The NM_000233.4(LHCGR):​c.430G>A​(p.Val144Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000574 in 1,613,880 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V144F) has been classified as Pathogenic.

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00060 ( 3 hom. )

Consequence

LHCGR
NM_000233.4 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 3.88

Publications

16 publications found
Variant links:
Genes affected
LHCGR (HGNC:6585): (luteinizing hormone/choriogonadotropin receptor) This gene encodes the receptor for both luteinizing hormone and choriogonadotropin. This receptor belongs to the G-protein coupled receptor 1 family, and its activity is mediated by G proteins which activate adenylate cyclase. Mutations in this gene result in disorders of male secondary sexual character development, including familial male precocious puberty, also known as testotoxicosis, hypogonadotropic hypogonadism, Leydig cell adenoma with precocious puberty, and male pseudohermaphtoditism with Leydig cell hypoplasia. [provided by RefSeq, Jul 2008]
STON1-GTF2A1L (HGNC:30651): (STON1-GTF2A1L readthrough) STON1-GTF2A1L mRNAs are infrequent but naturally occurring read-through products of the neighboring STON1 and GTF2A1L genes. These transcripts encode fusion proteins composed of the vast majority of each of the individual elements, stonin 1 and general transcription factor IIA, 1-like. Alternative splicing results in multiple transcript variants. The significance of these read-through variants and the function of the resulting protein products have not yet been determined. [provided by RefSeq, Oct 2010]
GTF2A1L (HGNC:30727): (general transcription factor IIA subunit 1 like) The assembly and stability of the RNA polymerase II transcription pre-initiation complex on a eukaryotic core promoter involve the effects of transcription factor IIA (TFIIA) on the interaction between TATA-binding protein (TBP) and DNA. This gene encodes a germ cell-specific counterpart of the large (alpha/beta) subunit of general transcription factor TFIIA that is able to stabilize the binding of TBP to DNA and may be uniquely important to testis biology. Alternative splicing for this locus has been observed and two variants, encoding distinct isoforms, have been identified. Co-transcription of this gene and the neighboring upstream gene generates a rare transcript (SALF), which encodes a fusion protein comprised of sequence sharing identity with each individual gene product. [provided by RefSeq, Mar 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-48723650-C-A is described in ClinVar as Pathogenic. ClinVar VariationId is 14411.Status of the report is no_assertion_criteria_provided, 0 stars.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 29 curated pathogenic missense variants (we use a threshold of 10). The gene has 8 curated benign missense variants. Gene score misZ: 0.16259 (below the threshold of 3.09). Trascript score misZ: -0.035144 (below the threshold of 3.09). GenCC associations: The gene is linked to Leydig cell hypoplasia, type 1, familial male-limited precocious puberty.
BP4
Computational evidence support a benign effect (MetaRNN=0.029079586).
BP6
Variant 2-48723650-C-T is Benign according to our data. Variant chr2-48723650-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 336466.
BS1
Variant frequency is greater than expected in population nfe. GnomAdExome4 allele frequency = 0.000597 (873/1461610) while in subpopulation NFE AF = 0.000752 (836/1111790). AF 95% confidence interval is 0.000709. There are 3 homozygotes in GnomAdExome4. There are 410 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000233.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LHCGR
NM_000233.4
MANE Select
c.430G>Ap.Val144Ile
missense
Exon 5 of 11NP_000224.2P22888-1
STON1-GTF2A1L
NM_001198593.2
c.3441+51970C>T
intron
N/ANP_001185522.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LHCGR
ENST00000294954.12
TSL:1 MANE Select
c.430G>Ap.Val144Ile
missense
Exon 5 of 11ENSP00000294954.6P22888-1
ENSG00000279956
ENST00000602369.3
TSL:5
n.355G>A
non_coding_transcript_exon
Exon 4 of 13ENSP00000473498.1R4GN57
LHCGR
ENST00000405626.5
TSL:5
c.430G>Ap.Val144Ile
missense
Exon 5 of 10ENSP00000386033.1E7ENI1

Frequencies

GnomAD3 genomes
AF:
0.000348
AC:
53
AN:
152152
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000632
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000279
AC:
70
AN:
251144
AF XY:
0.000280
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000573
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000597
AC:
873
AN:
1461610
Hom.:
3
Cov.:
30
AF XY:
0.000564
AC XY:
410
AN XY:
727126
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33470
American (AMR)
AF:
0.00
AC:
0
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39680
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86250
European-Finnish (FIN)
AF:
0.000243
AC:
13
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000752
AC:
836
AN:
1111790
Other (OTH)
AF:
0.000364
AC:
22
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
41
82
124
165
206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000348
AC:
53
AN:
152270
Hom.:
0
Cov.:
32
AF XY:
0.000215
AC XY:
16
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0000722
AC:
3
AN:
41546
American (AMR)
AF:
0.000196
AC:
3
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4816
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000632
AC:
43
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000482
Hom.:
0
Bravo
AF:
0.000298
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.000329
AC:
40
EpiCase
AF:
0.000491
EpiControl
AF:
0.000474

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
not provided (2)
-
-
1
Gonadotropin-independent familial sexual precocity (1)
-
-
1
Hypergonadotropic hypogonadism (1)
-
-
1
Leydig cell agenesis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
15
DANN
Benign
0.68
DEOGEN2
Benign
0.066
T
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.058
N
LIST_S2
Benign
0.53
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.029
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-1.6
N
PhyloP100
3.9
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
0.37
N
REVEL
Uncertain
0.30
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0010
B
Vest4
0.25
MVP
0.85
MPC
0.070
ClinPred
0.014
T
GERP RS
4.8
Varity_R
0.040
gMVP
0.27
Mutation Taster
=84/16
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121912539; hg19: chr2-48950789; COSMIC: COSV99038872; COSMIC: COSV99038872; API